GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Petlife Pharmaceuticals Inc (OTCPK:PTLF) » Definitions » 6-1 Month Momentum %

Petlife Pharmaceuticals (Petlife Pharmaceuticals) 6-1 Month Momentum % : -80.00% (As of May. 30, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Petlife Pharmaceuticals 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-05-30), Petlife Pharmaceuticals's 6-1 Month Momentum % is -80.00%.

The industry rank for Petlife Pharmaceuticals's 6-1 Month Momentum % or its related term are showing as below:

PTLF's 6-1 Month Momentum % is not ranked
in the Drug Manufacturers industry.
Industry Median: -3.13 vs PTLF: -80.00

Competitive Comparison of Petlife Pharmaceuticals's 6-1 Month Momentum %

For the Drug Manufacturers - Specialty & Generic subindustry, Petlife Pharmaceuticals's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Petlife Pharmaceuticals's 6-1 Month Momentum % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Petlife Pharmaceuticals's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Petlife Pharmaceuticals's 6-1 Month Momentum % falls into.



Petlife Pharmaceuticals  (OTCPK:PTLF) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Petlife Pharmaceuticals  (OTCPK:PTLF) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Petlife Pharmaceuticals 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Petlife Pharmaceuticals's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Petlife Pharmaceuticals (Petlife Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
38 West Main Street, 6th Floor, Hancock, MD, USA, 21750
Petlife Pharmaceuticals Inc specializes in the research, development, sales, and support of advanced drugs and nutraceuticals for pet cancer and autoimmune related diseases such as arthritis. It develops potentiated veterinary cancer medications and nutraceuticals, under its tradename Vitalzul based on Escozine formula. The Vitalzul is a polarized, bioactive peptide extracted from the Blue Caribbean Scorpion (Rhopularus Princeps), which contains amino acids, proteins, and minerals.
Executives
Randy Steven White director, 10 percent owner, officer: President/Secretary/Treasurer OPLETALOVA 43, PRAGUE 2N 11000

Petlife Pharmaceuticals (Petlife Pharmaceuticals) Headlines